MedTrace Logo

Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer

NCT04302714 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2020-03-12

No results posted yet for this study

Summary

Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer: a multicenter prospective randomized study

Conditions

Interventions

PROCEDURE

Hysteroscopic injection

Hysteroscopic injection

PROCEDURE

Cervical injection

Cervical injection

Sponsors & Collaborators

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    lead OTHER

Principal Investigators

  • Antonino Ditto, MD · Fonsazione IRCCS Istituto Nazionale Tumori Milano

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-20
Primary Completion
2019-03-28
Completion
2020-02-25

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04302714 on ClinicalTrials.gov